# AMAG Pharmaceuticals

AMAG Pharmaceuticals is an Asset Manager based in Waltham, United States.

## Overview

- **Organization type:** Asset Manager
- **Headquarters:** Waltham, United States
- **Region:** North America
- **Address:** Waltham, MA, United States
- **Assets under management:** Undisclosed
- **Website:** amagpharma.com
- **LinkedIn:** https://www.linkedin.com/company/amag-pharmaceuticals

## Regulatory record

- **Reports private funds:** No

## About

AMAG Pharmaceuticals develops and commercializes specialty pharmaceutical products. The company markets an intravenous iron compound for treating iron deficiency anemia in adult patients with chronic kidney disease and an oral rinse for managing oral mucositis in the US. AMAG seeks to expand its portfolio with additional commercial-stage specialty pharmaceuticals.

## Sectors

- Healthcare Services

## Questions

### What happened to AMAG's legacy drug portfolio?

AMAG's legacy commercial products included Makena, a preterm-birth therapy that the FDA withdrew in 2023 after confirmatory trials failed to show benefit, and Feraheme, an anemia treatment still on the market. Prior to the Altaris acquisition, AMAG divested its Cord Blood Registry service and the MuGard cancer-support product line as part of a broader restructuring.

## Related profiles

- [Borealis Ventures](https://altss.com/profile/borealis)
- [MakeMyTrip (India) Private Limited](https://altss.com/profile/makemytrip-india-private-limited)

---

Last updated: 2026-06-03T20:00:00.000Z

Canonical page: https://altss.com/profile/amag-pharmaceuticals

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology